ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oric Pharmaceuticals Inc

Oric Pharmaceuticals Inc (ORIC)

8.96
-0.06
(-0.67%)
Closed December 11 4:00PM
8.96
0.00
( 0.00% )
Pre Market: 4:05AM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.000.000.000.000.000.00 %00-
5.002.855.900.004.3750.000.00 %00-
7.501.304.400.002.850.000.00 %00-
10.000.100.250.350.1750.000.00 %03,237-
12.500.000.000.000.000.000.00 %00-
15.000.000.000.000.000.000.00 %00-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.000.750.000.000.000.00 %00-
5.000.000.000.000.000.000.00 %00-
7.500.000.000.000.000.000.00 %00-
10.000.651.900.821.2750.000.00 %06-
12.500.000.000.000.000.000.00 %00-
15.000.000.000.000.000.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PALIPalisade Bio Inc
$ 2.95
(110.71%)
7.47M
AMPGAmplitech Group Inc
$ 2.80
(45.08%)
6.46M
DBVTDBV Technologies SA
$ 4.39
(33.43%)
2.31M
WHLRWheeler Real Estate Investment Trust Inc
$ 5.85
(31.17%)
934.14k
ECBKECB Bancorp Inc
$ 19.00
(25.99%)
101
PNBKPatriot National Bancorp Inc
$ 1.08
(-58.78%)
13
AVGRAvinger Inc
$ 0.42
(-48.78%)
20.11k
SPGCSacks Parente Golf Inc
$ 0.784
(-44.00%)
15.36k
HEPAHepion Pharmaceuticals Inc
$ 0.36
(-38.46%)
1
BCTXBriaCell Therapeutics Corporation
$ 0.689
(-37.36%)
80.4k
PALIPalisade Bio Inc
$ 2.95
(110.71%)
7.47M
AMPGAmplitech Group Inc
$ 2.80
(45.08%)
6.46M
RGTIRigetti Computing Inc
$ 6.82
(-7.59%)
2.49M
RZLVRezolve AI Ltd
$ 2.23
(12.06%)
2.35M
DBVTDBV Technologies SA
$ 4.39
(33.43%)
2.31M

ORIC Discussion

View Posts
Monksdream Monksdream 3 months ago
ORIC under $10
👍️0
Monksdream Monksdream 5 months ago
ORIC under $10
👍️0
Monksdream Monksdream 5 months ago
ORIC under $10
👍️0
Monksdream Monksdream 7 months ago
ORIC 10Q due 5/6
👍️0
Monksdream Monksdream 7 months ago
ORIC under $10
👍️0
Monksdream Monksdream 9 months ago
ORIC 10Q due 3/16
👍️0
Monksdream Monksdream 9 months ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 9 months ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 9 months ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 10 months ago
ORIC new 52 weewk high
👍️0
Monksdream Monksdream 11 months ago
ORIC new 52 week high
👍️0
TheFinalCD TheFinalCD 2 years ago
$ORIC LOOKS LIKE $6 COMING
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: Tapped $5.40....... still got steam

It ain't over yet





GO $ORIC
👍️0
DH112 DH112 2 years ago
Today is green fields
👍️0
TheFinalCD TheFinalCD 2 years ago
Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: 5.25 now........................... lets get to $10

I know you can do it babyyyyyyyyyyyyyyyyy


GO $ORIC
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC : Now at 4.90

YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

Me likes it


GO $ORIC
👍️0
crudeoil24 crudeoil24 2 years ago
Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


Write to Dean Seal at dean.seal@wsj.com


(END) Dow Jones Newswires

December 22, 2022 07:25 ET (12:25 GMT)
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

Letssssssss goooooooooooooooooo.


Added 5k shares here at 4.30

Great NEWS


https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

GO $ORIC
👍️0

Your Recent History

Delayed Upgrade Clock